Vimentin is a type III intermediate filament protein that functions as a major structural component of the cytoskeleton in mesenchymal cells, astrocytes, and neurons during development. While Vimentin is largely replaced by neurofilaments in mature neurons, it continues to play essential roles in glial cells, activated astrocytes, and during neuronal stress responses.
In neurodegenerative diseases, Vimentin re-expression and phosphorylation are hallmarks of neuronal injury, and its detection in cerebrospinal fluid and blood serves as a biomarker for neuroaxonal damage.
| Attribute |
Value |
| Protein Name |
Vimentin |
| Gene |
VIM |
| UniProt ID |
P08670 |
| Molecular Weight |
57 kDa |
| Subclass |
Type III Intermediate Filament |
| Chromosome |
10p13 |
| Expression |
Mesenchymal cells, astrocytes, developing neurons |
¶ Structure and Biochemistry
Vimentin is a 466 amino acid protein organized into distinct structural domains:
- Head Domain (1-96): Highly basic N-terminal domain involved in filament assembly initiation
- Rod Domain (97-410): Central α-helical rod domain with conserved helix termination motifs
- Tail Domain (411-466): C-terminal domain involved in protein-protein interactions
Vimentin forms intermediate filaments (10 nm diameter) through a stepwise process:
- Dimer Formation: Two Vimentin monomers form a coiled-coil dimer
- Tetramer Assembly: Two dimers associate to form a tetramer (8-chain unit)
- Unit Length Filaments: Tetramers assemble into unit length filaments
- Filament Elongation: End-to-end and lateral association creates mature filaments
Vimentin undergoes extensive post-translational modifications:
- Phosphorylation: Ser/Thr kinases (PKC, CDK1, GSK3β) regulate filament disassembly
- Acetylation: Affects filament stability and function
- Oxidation: Reactive oxygen species modify Vimentin in disease states
During CNS development, Vimentin plays critical roles:
- Neuronal Migration: Scaffold for neuronal movement
- Neurite Outgrowth: Provides structural support for axonal/dendritic extension
- Synapse Formation: Involved in synaptic plasticity
- Glial Development: Essential for astrocyte and Schwann cell development
In mature CNS, Vimentin is primarily expressed in astrocytes:
- Astrocyte Structure: Maintains astrocyte morphology
- Reactive Gliosis: Upregulated in reactive astrocytes
- Blood-Brain Barrier: Supports endothelial cell interactions
- Neuronal Support: Provides trophic factor scaffolding
Vimentin functions as a damage-associated molecular pattern (DAMP):
- DAMPs Receptor: Extracellular Vimentin binds to TLRs
- Phagocytosis: Mediates clearance of debris
- Autoimmunity: Anti-Vimentin antibodies in autoimmune conditions
Vimentin alterations are prominent in AD:
- Vimentin is upregulated in reactive astrocytes surrounding amyloid plaques
- Forms part of the astroglial response in AD
- GFAP/Vimentin double-positive astrocytes are abundant
- Vimentin is incorporated into some NFT-like structures
- Co-localizes with phosphorylated tau in certain cases
- May serve as a scaffold for filamentous inclusions
- Vimentin in CSF correlates with disease progression
- Vimentin fragments in blood as AD biomarkers
Vimentin contributes to PD pathogenesis:
- Vimentin-positive astrocytes in substantia nigra
- Reactive gliosis in PD brain
- Contributes to neuroinflammation
- Vimentin may sequester α-synuclein aggregates
- Altered in models of α-synucleinopathy
- Role in Lewy body formation
Vimentin is altered in ALS:
- Motor Neuron Pathology: Accumulation in motor neurons
- Glial Response: Robust upregulation in astrocytes
- Biomarker: Vimentin in CSF as disease marker
- Therapeutic Target: Anti-Vimentin immunotherapy approaches
Vimentin is involved in prion pathogenesis:
- PrPsc deposition triggers Vimentin alterations
- Astrocytic Vimentin in prion disease
- Potential role in prion spread
Vimentin is a sensitive marker for neurotrauma:
- Rapidly released following injury
- Biomarker for axonal damage
- Correlates with injury severity
Vimentin and its fragments serve as biomarkers:
| Fluid |
Application |
Status |
| CSF |
Neurodegeneration |
Research |
| Blood |
TBI |
Clinical use |
| Tears |
PD screening |
Research |
- Anti-Vimentin Strategies: Immunotherapy approaches
- Phosphorylation Modulation: Kinase inhibitors
- Aggregation Inhibitors: Preventing pathological aggregation
- Astrocyte Modulation: Targeting reactive gliosis
Neurofilament (NF-L, NF-M, NF-H)
↑
Vimentin
↓
GFAP (Astrocytes)
↓
α-Internexin
| Protein |
Interaction |
Functional Consequence |
| GFAP |
Co-assembly |
Astrocyte IF network |
| Nestin |
Heterodimerization |
Stem cell IF |
| PKC |
Phosphorylation |
Filament disassembly |
| CDK1 |
Phosphorylation |
Cell cycle regulation |
¶ Vimentin Mutations and Disease
Recessive VIM mutations cause GAN:
- Progressive motor and sensory neuropathy
- Kinky/hair appearance
- Intermediate filament accumulation
- Scarf syndrome (VIM mutations)
- Cataract with Vimentin mutations
- Dilated cardiomyopathy